Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M559Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-40.9EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)16.4Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.3PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M5,196,503ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BBH

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BBH is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BBH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Snow, Jeffery AlexanderSenior Officer 2016-12-08Buy90,000$5.122001.17view
DINWOODIE, TYLER WAYNE PAULSenior Officer 2016-12-08Buy10,000$0.1382653.85view
Grant, Cheryl AnnDirector, Senior Officer 2016-12-08Buy19,000$0.06179200view
Fowler, Christopher HectorSenior Officer 2016-12-08Buy429$32.1235.14view
Fowler, Christopher HectorSenior Officer 2016-12-08Buy14$32.11235.04view
Big Sky Uranium Inc.Director, Senior Officer 2016-12-08Buy2,500$1.129505.36view
Roy, Claude10% Security Holder, Director, Senior Officer 2016-12-08Buy400$18.95467.7view
Roy, Claude10% Security Holder, Director, Senior Officer 2016-12-08Buy600$18.97467.11view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-12-08Buy15,000$0.1382653.85view
Skoda, Edward FranklinDirector 2016-12-08Buy25,000$0.2346673.91view

Quarterly/Annual Reports about BBH:

    News about BBH:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Why Valbenazine Studies Seem Promising Dec 01 2016
    Epclusa: Gilead Sciences’s Pan-Genotype Product Dec 01 2016
    Trump Effect Elevated These Sector ETFs to Rank #1 Nov 30 2016
    Understanding Allergan’s 3Q16 Revenue Stream Nov 29 2016
    VanEck Announces Preliminary Year-End Distribution Estimates for VanEck Vectors Equity ETFs Nov 22 2016
    5 Reasons to Buy 5 Low P/E Biotech ETFs Nov 14 2016
    Generic-drug maker ETF could outperform biotech peers under Clinton Nov 08 2016
    Biotech ETFs Slumping on Q3 Results Nov 08 2016
    Healthcare ETFs in the Spotlight as Election Approaches Nov 07 2016
    Treasury and Biotech: 2 ETFs to Watch on Outsized Volume Nov 07 2016
    Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech Oct 20 2016
    ETFs to Play as Biotech Juggles Election & Earnings Oct 17 2016
    Bank and Biotech: 2 ETFs to Watch on Outsized Volume Oct 13 2016
    Illumina's Pain Infects Biotech ETFs Oct 11 2016
    How Could Robo-Advisors Change Investing? Oct 05 2016
    Innovation In Focus For European ETFs Oct 05 2016
    VanEck to Ring The Nasdaq Stock Market Opening Bell Sep 12 2016
    Politic-proofing your portfolio: Pro Sep 09 2016
    Clinton's Proposal To Combat Drug Price Hikes Sep 02 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)